allicin has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arditti, FD; Berrebi, A; Miron, T; Shvidel, L; Wilchek, M | 1 |
| Arditti, FD; Berrebi, A; Mirelman, D; Miron, T; Rabinkov, A; Reisner, Y; Wilchek, M | 1 |
2 other study(ies) available for allicin and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
S-allyl derivatives of 6-mercaptopurine are highly potent drugs against human B-CLL through synergism between 6-mercaptopurine and allicin.
Topics: Allyl Compounds; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Cell Membrane Permeability; Disease Models, Animal; Disulfides; DNA; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mercaptopurine; Mice; Mice, Inbred ICR; Oxidation-Reduction; Prodrugs; Sulfhydryl Compounds; Sulfinic Acids | 2012 |
Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Apoptosis; Carbon-Sulfur Lyases; Chimera; Disulfides; Dose-Response Relationship, Drug; Humans; Immunotoxins; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Mice, Inbred BALB C; Rituximab; Sulfinic Acids; Tumor Cells, Cultured | 2005 |